Paul Vigano Sells 1,000,000 Shares of Aveanna Healthcare (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder Paul Vigano sold 1,000,000 shares of the stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $8.00, for a total transaction of $8,000,000.00. Following the sale, the insider directly owned 245,251 shares of the company’s stock, valued at $1,962,008. The trade was a 80.31% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Aveanna Healthcare Stock Up 1.5%

AVAH traded up $0.12 during trading on Friday, hitting $8.61. The stock had a trading volume of 953,109 shares, compared to its average volume of 1,436,922. The stock has a 50 day simple moving average of $7.10 and a two-hundred day simple moving average of $7.57. The company has a debt-to-equity ratio of 5.35, a quick ratio of 1.47 and a current ratio of 1.47. Aveanna Healthcare Holdings Inc. has a twelve month low of $3.73 and a twelve month high of $10.32. The company has a market capitalization of $1.87 billion, a PE ratio of 7.29, a PEG ratio of 0.87 and a beta of 1.93.

Aveanna Healthcare (NASDAQ:AVAH) last issued its quarterly earnings data on Thursday, May 14th. The company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.13 by $0.05. The firm had revenue of $647.91 million during the quarter, compared to analyst estimates of $613.22 million. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The company’s quarterly revenue was up 15.9% on a year-over-year basis. On average, research analysts predict that Aveanna Healthcare Holdings Inc. will post 0.65 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts have weighed in on AVAH shares. Barclays lowered their price target on Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating for the company in a report on Monday, May 18th. Truist Financial increased their price objective on shares of Aveanna Healthcare from $8.00 to $9.00 and gave the company a “hold” rating in a research report on Wednesday, May 20th. BMO Capital Markets dropped their target price on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a research report on Friday, March 20th. Raymond James Financial upgraded shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price target on the stock in a research note on Friday, March 20th. Finally, Stephens upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $10.00 to $11.00 in a research note on Friday, May 15th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $10.50.

Institutional Investors Weigh In On Aveanna Healthcare

A number of large investors have recently bought and sold shares of the company. Dynamic Technology Lab Private Ltd increased its holdings in Aveanna Healthcare by 8.9% in the 3rd quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock worth $126,000 after buying an additional 1,151 shares during the period. Barclays PLC lifted its stake in Aveanna Healthcare by 0.8% during the 3rd quarter. Barclays PLC now owns 179,359 shares of the company’s stock valued at $1,591,000 after acquiring an additional 1,366 shares during the period. Franklin Resources Inc. boosted its holdings in shares of Aveanna Healthcare by 4.5% in the 3rd quarter. Franklin Resources Inc. now owns 35,630 shares of the company’s stock valued at $316,000 after acquiring an additional 1,528 shares during the last quarter. Intech Investment Management LLC boosted its holdings in shares of Aveanna Healthcare by 9.8% in the 4th quarter. Intech Investment Management LLC now owns 19,483 shares of the company’s stock valued at $159,000 after acquiring an additional 1,739 shares during the last quarter. Finally, Balboa Wealth Partners increased its stake in shares of Aveanna Healthcare by 13.5% in the fourth quarter. Balboa Wealth Partners now owns 16,890 shares of the company’s stock worth $138,000 after acquiring an additional 2,007 shares during the period. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.